What's in Raymond T. Chung, MD's pipeline?

Raymond T. Chung, MD has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Raymond T. Chung, MD's portfolio?

Top competitors by shared drug class: AbbVie, Istituto Clinico Humanitas, Massachusetts General Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/raymond-t-chung-md.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Raymond T. Chung, MD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Raymond T. Chung, MD pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
glecaprevir/pibrentasvir tablets	glecaprevir/pibrentasvir tablets	marketed	Direct-acting antiviral combination (NS3/4A protease inhibitor + NS5A inhibitor)	HCV NS3/4A protease and NS5A protein	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 1 shared drug class
Istituto Clinico Humanitas · 1 shared drug class
Massachusetts General Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Raymond T. Chung, MD:

Cite this brief

Drug Landscape (2026). Raymond T. Chung, MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/raymond-t-chung-md. Accessed 2026-05-17.